Peripheral Vascular Disease
Survival in atherosclerotic renal artery stenosis: Its all about renal function, or is it?
Jeffrey W. Olin DO,
Corresponding Author
Jeffrey W. Olin DO
Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York 10029
Professor of Medicine; Director, Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1033, NY 10029
Search for more papers by this author
Jeffrey W. Olin DO,
Corresponding Author
Jeffrey W. Olin DO
Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, New York 10029
Professor of Medicine; Director, Vascular Medicine, Zena and Michael A. Wiener Cardiovascular Institute, Marie-Josée and Henry R. Kravis Center for Cardiovascular Health, Mount Sinai School of Medicine, One Gustave L. Levy Place, Box 1033, NY 10029
Search for more papers by this author
First published: 24 May 2007
No abstract is available for this article.
REFERENCES
- 1
Conlon PJ,
Little MA,
Pieper K,
Mark DB.
Severity of renal vascular disease predicts mortality in patients undergoing coronary angiography.
Kidney Int
2001;
60:
1490–1497.
- 2
Connolly JO,
Higgins RM,
Walters HL,
Mackie AD,
Drury PL, et al.
Presentation, clinical features and outcome in different patterns of atherosclerotic renovascular disease.
QJM
1994;
87:
413–421.
- 3
Dorros G,
Jaff M,
Mathiak L,
Dorros II,
Lowe A, et al.
Four-year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis.
Circulation
1998;
98:
642–647.
- 4
Go AS,
Chertow GM,
Fan D,
McCulloch CE,
Hsu CY.
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization.
N Engl J Med
2004;
351:
1296–1305.
- 5
Cooper CJ,
Murphy TP,
Matsumoto A,
Steffes M,
Cohen DJ, et al.
Stent revascularization for the prevention of cardiovascular and renal events among patients with renal artery stenosis and systolic hypertension: Rationale and design of the CORAL trial.
Am Heart J
2006;
152:
59–66.
